Perioperative prophylaxis for postcataract extraction endophthalmitis

International Ophthalmology Clinics

Volumn 47, Issue 2, 2007, Pages 1-14

  Kim, Jae Yong ^a   Ali, Rasha ^a   Cremers, Sandra Lora ^a   Henderson, Bonnie An ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEFAZOLIN; CEFUROXIME; CHLORAMPHENICOL; CYANOACRYLIC ACID OCTYL ESTER; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; FLOMOXEF; GATIFLOXACIN; GENTAMICIN; LATAMOXEF; LINEZOLID; MOXIFLOXACIN; OZONE; POVIDONE IODINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN; WATER;

BLEPHARITIS; CATARACT EXTRACTION; CLINICAL TRIAL; CONJUNCTIVA DISEASE; CONJUNCTIVITIS; DACRYOCYSTITIS; DIABETES MELLITUS; ENDOPHTHALMITIS; HUMAN; IMMUNE STATUS; IMMUNOSUPPRESSIVE TREATMENT; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; SINGLE DRUG DOSE; SKIN DISEASE; SURGICAL RISK; SUTURE;

ANTIBIOTIC PROPHYLAXIS; CATARACT EXTRACTION; ENDOPHTHALMITIS; EYE INFECTIONS; HUMANS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 34248158678     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e318036bc39     Document Type: Review

References (104)

1. Wejde G, Montan P, Lundstrom M, et al. Endophthalmitis following cataract surgery in Sweden: national prospective survey 1999-2001. Acta Ophthalmol Scand. 2005;83:7-10.
2. Li J, Morlet N, Ng JQ, et al., Team EPSWA. Significant nonsurgical risk factors for endophthalmitis after cataract surgery: EPSWA fourth report. Invest Ophthalmol Vis Sci. 2004;45:1321-1328.
3. Semmens JB, Li J, Morlet N, et al. Trends in cataract surgery and post-operative endophthalmitis in Western Australia (1980-1998): the endophthalmitis population study of Western Australia. Clin Exp Ophthalmol. 2003;31:213-219.
4. Sandvig KU, Dannevig L. Postoperative endophthalmitis: establishment and results of a national registry. J Cataract Refract Surg. 2003;29:1273-1280.
5. Montan P, Lundstrom M, Stenevi U, et al. Endophthalmitis following cataract surgery in Sweden: the 1998 national prospective study. Acta Ophthalmol Scand. 2002;80:258-261.
6. Versteegh MF, Van Rij G. Incidence of endophthalmitis after cataract surgery in the Netherlands: several surgical techniques compared. Doc Ophthalmol. 2000;100:1-6.
7. Norregaard JC, Thoning H, Bernth-Petersen P, et al. Risk of endophthalmitis after cataract extraction: results from the international cataract surgery outcomes study. Br J Ophthalmol. 1997;81:102-106.
8. Schmitz S, Dick HB, Krummenauer F, et al. Endophthalmitis in cataract surgery: results of a German survey. Ophthalmology. 1999;106:1869-1877.
9. Desai P, Minassian DC, Reidy A. National cataract surgery survey 1997-8: a report of the results of the clinical outcomes. Br J Ophthalmol. 1999;83:1336-1340.
10. Miller JJ, Scott IU, Flynn HW, et al. Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol. 2005;139:983-987.
11. Jensen MK, Fiscella RG, Crandall AS, et al. A retrospective study of endophtalmitis rates comparing quinolone antibiotics. Am J Ophthalmol. 2005;139:141-148.
12. Mayer E, Cadman D, Ewings P, et al. A 10 year retrospective survey of cataract surgery and endophthalmitis in a single eye unit: injectable lenses lower the incidence of endophthalmitis. Br J Ophthalmol. 2003;87:867-869.
13. Riley AF, Malik TY, Grupcheva CN, et al. The Auckland cataract study: co-morbidity, surgical techniques, and clinical outcomes in a public hospital service. Br J Ophthalmol. 2002;86:185-190.
14. Eifrig CW, Flynn HW, Scott IU, et al. Acute-onset postoperative endophthalmitis: review of incidence and visual outcomes (1995-2001). Ophthalmic Surg Lasers. 2002;33:373-378.
15. Ernest J, Rejmont L, Pasta J, et al. Endophthalmitis after cataract surgery [in Czech]. Cesk Slov Oftalmol. 2000;56:351-356.
16. Colleaux KM, Hamilton WK. Effect of prophylactic antibiotics and incision type on the incidence of endophthalmitis after cataract surgery. Can J Ophthalmol. 2000;35:373-378.
17. Bohigian GM. A study of the incidence of culture-positive endophthalmitis after cataract surgery in an ambulatory care centre. Ophthalmic Surg Lasers. 1999;30:295-298.
18. Aaberg TM, Flynn HW, Schiffman J, et al. Nosocomial acute onset postoperative endophthalmitis survey: a 10-year review of incidence and outcomes. Ophthalmology. 1998;105:1004-1010.
19. Henderson BA, Ament CS, Kim JY, et al. Retrospective review of the rate of endophthalmitis with moxifloxacin use in cataract surgery. World Ophthalmology Congress, Sao Paulo, Brazil, 2006.
20. Morlet N, Li J, Semmens J, et al., Team EPSWA. The Endophthalmitis Population Study of Western Australia (EPSWA): first report. Br J Ophthalmol. 2003;87:574-576.
21. Speaker MG, Milch FA, Shah MK, et al. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology. 1991;98:639-649.
22. Bannerman TL, Rhoden DL, McAllister SK, et al. The source of coagulase-negative staphylococci in the Endophthalmitis Vitrectomy Study. A comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis. Arch Ophthalmol. 1997;115:357-361.
23. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol. 1996;122:1-17.
24. Forster RK, Abbott RL, Gelender H. Management of infectious endophthalmitis. Ophthalmology. 1980;87:313-318.
25. Mistlberger A, Ruckhofer J, Raithel E, et al. Anterior chamber contamination during cataract surgery with intraocular lens implantation. J Cataract Refract Surg. 1997;23:1064-1069.
26. Bialasiewicz AA, Welt R. Preoperative microbiologic diagnosis before elective intraocular interventions and prevention of infection with tobramycin eyedrops. Results of a multicenter study. Klin Monatsbl Augenheilkd. 1991;198:87-93.
27. Good WV, Hing S, Irvine AR, et al. Postoperative endophthalmitis in children after cataract surgery. J Paediatr Ophthalmol Strabismus. 1990;27:283-285.
28. Ram J. Reducing cataract surgery-related complications. Indian J Ophthalmol. 1999;47:153-154.
29. Johnson MW, Doft BH, Kelsey SL, et al., for the Endophthalmitis Vitrectomy Study Group. Relationship between clinical presentation and microbiologic spectrum. Ophthalmology. 1997;104:261-272.
30. Gicquel JJ, Quinton J, Salama B, et al. Staphylococcal endophthalmitis following cataract surgery in a patient with ocular rosacea. J Fr Ophtalmol. 2005;28:e7.
31. Wallin T, Parker J, Jin Y, et al. Cohort study of 27 cases of endophthalmitis at a single institution. J Cataract Refract Surg. 2005;31:735-741.
32. Lehmann OJ, Roberts CJ, Ikram K. Association between nonadministration of subconjuctival cefuroxime and postoperative endophthalmitis. J Cataract Refract Surg. 1997;23:889-893.
33. Tarkkanen A, Raivio V, Anttila VJ, et al. Fungal endophthalmitis caused by Paecilomyces variotii following cataract surgery: a presumed operating room airconditioning system contamination. Acta Ophthalmol Scand. 2004;82:232-235.
34. Schein OD, Steinberg EP, Javitt JC, et al. Variation in cataract surgery practice and clinical outcomes. Ophthalmology. 1994;101:1142-1152.
35. Callegan MC, Engelbert M, Parke DW II, et al. Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions. Clin Microbiol Rev. 2002;15:111-124.
36. Javitt JC, Vitale S, Canner JK. National outcomes of cataract extraction; endophthalmitis following inpatient surgery. Arch Ophthalmol. 1991;109:1085-1089.
37. Sandvig KU, Dannevig L. Postoperative endophthalmitis: establishment and results of a national registry. J Cataract Refract Surg. 2003;29:1273-1280.
38. Cooper BA, Holekamp NM, Bohigian G, et al. Case-control study of endophthalmitis after cataract surgery comparing scleral tunnel and clear corneal wounds. Am J Ophthalmol. 2003;136:300-305.
39. Krummenauer F, Kurz S, Dick HB. Epidemiological and health economical evaluation of intraoperative antibiosis as a protective agent against endophthalmitis after cataract surgery. Eur J Med Res. 2005;10:71-75.
40. Colleaux KM, Hamilton WK. Effect of prophylactic antibiotics and incision type on the incidence of endophthalmitis after cataract surgery. Can J Ophthalmol. 2000;35:373-378.
41. Miller JJ, Scott IU, Flynn HW, et al. Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol. 2005;139:983-987.
42. McDonnell PJ, Taban M, Sarayba M, et al. Dynamic morphology of clear corneal cataract incisions. Ophthalmology. 2003;110:2342-2348.
43. Ernest PH, Fenzl R, Lavery KT, et al. Relative stability of clear corneal incision in a cadaver eye model. J Cataract Refract Surg. 1995;21:39-42.
44. Langerman DW. Architectural design of a self-sealing corneal tunnel, single-hinge incision. J Cataract Refract Surg. 1994;20:84-88.
45. Olson RJ. Reducing the risk of postoperative endophthalmitis. Surv Ophthalmol. 2004;49:S55-S61.
46. Herretes S, Stark WJ, Pirouzmanesh A, et al. Inflow of ocular surface fluid into the anterior chamber after phacoemulsification through sutureless corneal cataract wounds. Am J Ophthalmol. 2005;140:737-740.
47. Taban M, Rao B, Reznik J, et al. Dynamic morphology of sutureless cataract wounds-effect of incision angle and location. Surv Ophthalmol. 2004;49(S2):S62-S72.
48. Shingleton BJ, Wadhwani RA, O'Donoghue MW, et al. Evaluation of intraocular pressure in the immediate period after phacoemulsification. J Cataract Refract Surg. 2001;27:524-527.
49. Ciulla T, Starr M, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery. Ophthalmology. 2002;109:13-26.
50. John T, Sims M, Hoffmann C. Intraocular bacterial contamination during sutureless, small incision, single-port phacoemulsification. J Cataract Refract Surg. 2000;26:1786-1791.
51. Koc F, Akcam Z, Kuruoglu S, et al. Does surgical technique influence cataract surgery contamination? Eur J Ophthalmol. 2001;11:31-36.
52. Leong J, Shah R, McCluskey P, et al. Bacterial contamination of the anterior chamber during phacoemulsification cataract surgery. J Cataract Refract Surg. 2002;28:826-833.
53. Egger SF, Huber-Spitzy V, Scholda C, et al. Bacterial contamination during extracapsular cataract extraction; prospective study on 200 consecutive patients. Ophthalmologica. 1994;208:77-81.
54. Manners TD, Chitkara DK, Marsh PJ, et al. Anterior chamber aspirate cultures in small incision cataract surgery. Br J Ophthalmol. 1995;79:873.
55. Shockley R, Jay W, Fishman P, et al. Effect of inoculum size on the induction of endophthalmitis in aphakic rabbit eyes. Acta Ophthalmol. 1985;63:35-38.
56. Liesegang TJ. Use of antimicrobials to prevent postoperative infection in patients with cataracts. Curr Opin Ophthalmol. 2001;12:68-74.
57. Zamora JL. Chemical and microbiologic characteristics and toxicity of povidone-iodine solutions. Am J Surg. 1986;151:400-1406.
58. Rodeheaver G, Bellamy W, Kody M, et al. Bactericidal activity and toxicity of iodine-containing solutions in wounds. Arch Surg. 1982;117:181-186.
59. Gocke DJ, Ponticas S, Pollack W. In vitro studies of the killing of clinical isolates by povidone-iodine solutions. J Hosp Infect. 1985;6(suppl A):59-66.
60. Apt L, Isenberg SJ, Yoshimori R, et al. The effect of povidone-iodine solution applied at the conclusion of ophthalmic surgery. Am J Ophthalmol. 1995;119:701-705.
61. Berkelman RL, Holland BW, Anderson RL. Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J Clin Microbiol. 1982;15:635-639.
62. Goguen E, Roberts C. Perioperative pharmacology in cataract surgery. Insight. 2005;30:23-28.
63. Apt L, Isenberg S, Yoshimori R, et al. Chemical preparation of the eye in ophthalmic surgery III: effect of povidone-iodine on the conjunctiva. Arch Ophthalmol. 1984;102:728-772.
64. Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991;98:1769-1775.
65. Mino de Kaspar H, Chang RT, Singh K, et al. Prospective randomized comparison of 2 different methods of 5% povidone-iodine applications for anterior segment intraocular surgery. Arch Ophthalmol. 2005;123:161-165.
66. Alp BN, Elibol O, Sargon MF, et al. The effect of povidone iodine on the corneal endothelium. Cornea. 2000;19:546-550.
67. Barza M, Doft B, Lynch E. Ocular penetration of ceftriaxone, ceftazidime, and vancomycin after subconjunctival injection in humans. Arch Ophthalmol. 1993;111:492-494.
68. Lehmann OJ, Roberts CJ, Ikram K. Association between nonadministration of subconjuctival cefuroxime and postoperative endophthalmitis. J Cataract Refract Surg. 1997;23:889-893.
69. Krummenauer F, Kurz S, Dick HB. Epidemiological and health economical evaluation of intraoperative antibiosis as a protective agent against endophthalmitis after cataract surgery. Eur J Med Res. 2005;10:71-75.
70. Alfonso EC, FlynnHWJr. Controversies in endophthalmitis prevention. The risk for emerging resistance to vancomycin. Arch Ophthalmol. 1995;113:1369-1370.
71. Sobaci G, Tuncer K, Tas A, et al. The effect of intraoperative antibiotics in irrigating solutions on aqueous humor contamination and endophthalmitis after phacoemulsification surgery. Eur J Ophthalmol. 2003;13:773-778.
72. Mendivil SA, Mendivil MP. The effect of topical povidone-iodine, intraocular vancomycin or both on aqueous humor cultures at the time of cataract surgery. Am J Ophthalmol. 2001;131:293-300.
73. Storr-Paulsen A, Holten-AndersenW, Moller KT. Antibiotics in irrigation solution for cataract surgery. Acta Ophthalmol Scand. 1998;76:180-183.
74. Feys J, Salvanet-Bouccara A, Edmond JP, et al. Vancomycin prophylaxis and intraocular contamination during cataract surgery. J Cataract Refract Surg. 1997;23:894-897.
75. Schwalbe RS, Stapleton JT, Gilligan PH. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med. 1987;316:927-931.
76. Seppala H, Al-Juhaish M, Jarvinen H, et al. Effect of prophylactic antibiotics on antimicrobial resistance of viridans streptococci in the normal flora of cataract surgery patients. J Cataract Refract Surg. 2004;30:307-315.
77. Montan PG, Wejde G, Koranyi G, et al. Prophylactic intracameral cefuroxime-efficacy in preventing endophthalmitis after cataract surgery. J Catarct Refract Surg. 2002;28:977-981.
78. Wejde G, Samolov B, Seregard S, et al. Risk factors for endophthalmitis following cataract surgery: a retrospective case-control study. J Hosp Infect. 2005;61:251-256.
79. Kowalski RP, Romanowski EG, Mah FS, et al. Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model. Am J Ophthalmol. 2004;138:33-37.
80. Allen HF, Mangiaracine AB. Bacterial endophthalmitis after cataract extraction. II. Incidence in 36,000 consecutive operations with special reference to preoperative topical antibiotics. Arch Ophthalmol. 1974;91:3-7.
81. Masket S. Preventing, diagnosing, and treating endophthalmitis. J Cataract Refract Surg. 1998;24:725-726.
82. Ta CN, Egbert PR, Singh K, et al. Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery. Ophthalmology. 2002;109:2036-2041.
83. Isenberg S, Apt L, Yoshimori R, et al. Chemical preparation of the eye in ophthalmic surgery IV: comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic. Arch Ophthalmol. 1985;103:1340-1342.
84. De Kaspar HM, Chang RT, Shriver EM, et al. Three-day application of topical ofloxacin reduces the contamination rate of microsurgical knives in cataract surgery: a prospective randomized study. Ophthalmology. 2004;111:1352-1355.
85. Goguen E, Roberts C. Perioperative pharmacology in cataract surgery. Insight. 2005;30:23-28.
86. Hanioglu-Kargi S, Basci N, Soysal H, et al. The penetration of ofloxacin into human aqueous humor given by various routes. Eur J Ophthalmol. 1998;8:33-36.
87. Kobayakawa S, Tochikubo T, Tsuji A. Penetration of levofloxacin into human aqueous humor. Ophthalmic Res. 2003;35:97-101.
88. Yalvac IS, Basci NE, Bozkurt A, et al. Penetration of topically applied ciprofloxacin and ofloxacin into the aqueous humor and vitreous. J Cataract Refractive Surg. 2003;29:487-491.
89. Goldstein MH, Kowalski RP, Gordon J. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Ophthalmology. 1999;106:1313-1318.
90. Alexandrakis G, Alfonso EC, Miller D. Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolones. Ophthalmology. 2000;107:1497-1502.
91. Mather R, Karenchak LM, Romanowski EG, et al. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol. 2002;133:463-466.
92. Levine JM, Noecker RJ, Lane LC, et al. Aqueous penetration of gatifloxacin and levofloxacin into the rabbit aqueous humor following topical dosing. J Ocul Pharmacol Ther. 2004;20:210-216.
93. Levine JM, Noecker RJ, Lane LC, et al. Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing. J Cataract Refract Surg. 2004;30:2177-2182.
94. Kampougeris G, Antoniadou A, Kavouklis E, et al. Penetration of moxifloxacin into the human aqueous humour after oral administration. Br J Ophthalmol. 2005;89:628-631.
95. Hariprasad SM, Shah GK, Mieler WF, et al. Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Arch Ophthalmol. 2006;124:178-182.
96. Hariprasad SM, Mieler WF, Holz ER. Vitreous and aqueous penetration of orally administered gatifloxacin in humans. Arch Ophthalmol. 2003;121:345-350.
97. Mizuki N, Watanabe Y, Miyamoto M, et al. Flomoxef sodium and levofloxacin concentrations in aqueous humor. Ocul Immunol Inflamm. 2005;13:229-234.
98. Clemett D, Markham A. Linezolid. Drugs. 2000;59:815-828.
99. Prydal JI, Jenkins DR, Lovering A, et al. The pharmacokinetics of linezolid in the non-inflamed human eye. Br J Ophthalmol. 2005;89:1418-1419.
100. Bucci FA, Amico LM, Guerino A, et al. The effect of preoperative lid scrubs and levofloxacin on eyelid and conjunctival cultures prior to cataract surgery. Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL, 2003.
101. Rybak MJ, Hershberger E, Moldovan T, et al. In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin-intermediate and -resistant strains. Antimicrob Agents Chemother. 2000;44:1062-1066.
102. Ram J. Reducing cataract surgery-related complications. Indian J Ophthalmol. 1999;47:153-154.
103. Takahashi H, Fujimoto C, Matsui H, et al. Anterior chamber irrigation with an ozonated solution as prophylaxis against infectious endophthalmitis. J Cataract Refract Surg. 2004;30:1773-1780.
104. Meskin SW, Ritterband DC, Shapiro DE, et al. Liquid bandage (2-octyl cyanoacrylate) as a temporary wound barrier in clear corneal cataract surgery. Ophthalmology. 2005;112:2015-2021.